Skip to content

DexCom DXCM Operating Lease Right-of-Use Assets in Other Assets

Other financials

Income statement

See full
Revenue$1.2B+15.0%
Gross profit$750.3M+27.4%
Operating income$255.3M+90.9%
Net income$199.5M+89.3%
EPS (diluted)$0.51+88.9%

Balance sheet

See full
Cash & equivalents$1.1B+23.4%
Total debt$143.0M+2.2%
Total equity$3.0B+30.5%
Total assets$6.6B-1.8%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation

See full
Market cap$27.61B-21.4%
Enterprise value$26.63B-21.9%
P/E29.7×-31.8×
P/S5.7×-2.4×

Profitability

See full
Gross margin61.5%+2.1pp
Operating margin21.4%+6.2pp
Net margin19.3%+6.4pp
FCF margin29.7%+15.8pp

Returns & leverage

See full
Return on equity35.6%+11.9pp
Debt / equity0.0×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's operating lease right-of-use assets in other assets.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DexCom's operating lease right-of-use assets in other assets?
DexCom (DXCM) reported operating lease right-of-use assets in other assets of $73.1M in Q1 2026.
How has DexCom's operating lease right-of-use assets in other assets changed year-over-year?
DexCom's operating lease right-of-use assets in other assets increased by 23.7% year-over-year, from $59.1M to $73.1M.
What is the long-term trend for DexCom's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), DexCom's operating lease right-of-use assets in other assets has grown at a -3.7% compound annual growth rate (CAGR), from $93.3M to $77.4M.